These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 6212596

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Interpretive criteria of ceftibuten disk diffusion susceptibility tests according to the DIN 58 940 method.
    Kleinkauf N, Rodloff AC.
    Clin Microbiol Infect; 2001 Jun; 7(6):326-30. PubMed ID: 11442566
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Interpretive criteria for disk diffusion tests using 5-microgram cefdinir disks with rapidly growing clinical isolates.
    Jones RN, Erwin ME, Gooding BB.
    J Clin Microbiol; 1992 Apr; 30(4):1022-3. PubMed ID: 1572959
    [Abstract] [Full Text] [Related]

  • 26. Quality control and interpretive criteria for the azlocillin disk diffusion susceptibility test.
    Fass RJ.
    Antimicrob Agents Chemother; 1982 Jul; 22(1):28-31. PubMed ID: 7125631
    [Abstract] [Full Text] [Related]

  • 27. Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testing.
    Fuchs PC, Barry AL, Thornsberry C, Jones RN, Gavan TL, Gerlach EH, Sommers HM.
    Antimicrob Agents Chemother; 1980 Jul; 18(1):88-93. PubMed ID: 6251750
    [Abstract] [Full Text] [Related]

  • 28. Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing.
    Ayers LW, Jones RN, Barry AL, Thornsberry C, Fuchs PC, Gavan TL, Gerlach EH, Sommers HM.
    Antimicrob Agents Chemother; 1982 Nov; 22(5):859-77. PubMed ID: 6983862
    [Abstract] [Full Text] [Related]

  • 29. In vitro antimicrobial susceptibility testing using 30 microG and 75 microG U63196-E (cefpimizole AC-1370) disks.
    Jones RN, Thornsberry C, Barry AL.
    Diagn Microbiol Infect Dis; 1985 Jan; 3(1):87-92. PubMed ID: 3967476
    [Abstract] [Full Text] [Related]

  • 30. In vitro antibacterial spectrum of E1040 compared with those of cefpirome and ceftazidime and disk diffusion interpretive criteria for E1040.
    Fuchs PC, Jones RN, Barry AL.
    Antimicrob Agents Chemother; 1990 May; 34(5):914-7. PubMed ID: 2193626
    [Abstract] [Full Text] [Related]

  • 31. [In vitro comparative activity of 4 beta-lactams against Pseudomonas aeruginosa. Role of cefoperazone].
    Joly-Guillou ML, Bergogne-Berezin E, Verin-Prevost C.
    Pathol Biol (Paris); 1984 May; 32(5):408-11. PubMed ID: 6429612
    [Abstract] [Full Text] [Related]

  • 32. Disk diffusion susceptibility test interpretive criteria for GR69153, a new catechol-substituted cephalosporin.
    Jones RN, Erwin ME.
    J Clin Microbiol; 1991 Dec; 29(12):2890-2. PubMed ID: 1757568
    [Abstract] [Full Text] [Related]

  • 33. Criteria for disk susceptibility tests and quality control guidelines for the cefoperazone-sulbactam combination.
    Barry AL, Jones RN.
    J Clin Microbiol; 1988 Jan; 26(1):13-7. PubMed ID: 3343304
    [Abstract] [Full Text] [Related]

  • 34. Development of interpretive criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing of Streptococcus pneumoniae.
    Jorgensen JH, Swenson JM, Tenover FC, Ferraro MJ, Hindler JA, Murray PR.
    J Clin Microbiol; 1994 Oct; 32(10):2448-59. PubMed ID: 7814481
    [Abstract] [Full Text] [Related]

  • 35. Tentative disk diffusion susceptibility interpretive criteria for BMY-28142, a new cephalosporin.
    Fuchs PC, Jones RN, Barry AL, Thornsberry C.
    J Clin Microbiol; 1986 Mar; 23(3):634-6. PubMed ID: 3754266
    [Abstract] [Full Text] [Related]

  • 36. Proposal for agar disk diffusion interpretive criteria for susceptibility testing of bovine mastitis pathogens using cefoperazone 30μg disks.
    Feßler AT, Kaspar H, Lindeman CJ, Peters T, Watts JL, Schwarz S.
    Vet Microbiol; 2017 Feb; 200():65-70. PubMed ID: 26987627
    [Abstract] [Full Text] [Related]

  • 37. Preliminary disk diffusion susceptibility testing criteria for cefdaloxime (RU29246, HR-916 metabolite), a new orally administered cephalosporin.
    Jones RN, Erwin ME.
    J Clin Microbiol; 1992 May; 30(5):1297-300. PubMed ID: 1583135
    [Abstract] [Full Text] [Related]

  • 38. Azlocillin, a ureido penicillin active against Pseudomonas aeruginosa: interpretive zone standards and quality control parameters for tests with 75-mu g disks.
    Barry AL, Jones RN, Thornsberry C, Gavan TL.
    J Clin Microbiol; 1982 Jul; 16(1):135-40. PubMed ID: 6809788
    [Abstract] [Full Text] [Related]

  • 39. [Evaluation of in vitro antimicrobial activity of cefazolin alone and in combination with cefmetazole or flomoxef using agar dilution method and disk diffusion method].
    Matsuo K, Uete T.
    Jpn J Antibiot; 1992 Oct; 45(10):1253-66. PubMed ID: 1479676
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.